(Q43035171)

12 November 2017

Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans (English)

1 reference

12 November 2017

0 references

1 reference

1 reference

Ke-Qin Hu

1

1 reference

12 November 2017

Sue L Currie

2

1 reference

12 November 2017

Hui Shen

3

1 reference

12 November 2017

Ramsey C Cheung

4

1 reference

12 November 2017

Samuel B Ho

5

1 reference

12 November 2017

Edmund J Bini

6

1 reference

12 November 2017

John D McCracken

7

1 reference

12 November 2017

Tim Morgan

8

1 reference

12 November 2017

Norbert Bräu

9

1 reference

12 November 2017

Warren N Schmidt

10

1 reference

12 November 2017

Lennox Jeffers

11

1 reference

12 November 2017

Teresa L Wright

12

1 reference

12 November 2017

VA HCV-001 Study Group

13

1 reference

12 November 2017

17 January 2007

1 reference

Digestive Diseases and Sciences

12 November 2017

1 reference

12 November 2017

52

1 reference

12 November 2017

2

1 reference

12 November 2017

570-578

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-006-9418-4

12 November 2017

0 references

cites work

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-006-9418-4

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

21 January 2018

1 reference

12 December 2020

Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus

1 reference

12 December 2020

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

12 December 2020

Host- and disease-specific factors affecting steatosis in chronic hepatitis C

1 reference

12 December 2020

Steatosis and chronic hepatitis C virus infection: mechanisms and significance.

1 reference

12 December 2020

Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma

1 reference

12 December 2020

Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol

1 reference

12 December 2020

Clinical Profiles of Chronic Hepatitis C in a Major County Medical Center Outpatient Setting in United States

1 reference

12 December 2020

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

12 December 2020

Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults

1 reference

12 December 2020

Hepatitis C virus-induced hepatocellular steatosis.

1 reference

12 December 2020

Natural history of hepatitis C: its impact on clinical management

1 reference

12 December 2020

Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa

1 reference

12 December 2020

Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patients

1 reference

12 December 2020

Hepatitis C virus and liver steatosis: is it the virus? Yes it is, but not always

1 reference

12 December 2020

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients

1 reference

12 December 2020

High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.

1 reference

12 December 2020

Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical center

1 reference

12 December 2020

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

12 December 2020

Epidemiology of hepatitis C virus infection in American veterans

1 reference

12 December 2020

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

1 reference

12 December 2020

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

12 December 2020

Natural history of chronic hepatitis C

1 reference

12 December 2020

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

12 December 2020

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

1 reference

12 December 2020

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

1 reference

12 December 2020

Chronic hepatitis C in Latinos: natural history, treatment eligibility, acceptance, and outcomes.

1 reference

12 December 2020

Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection

1 reference

12 December 2020

Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion

1 reference

12 December 2020

An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation

1 reference

12 December 2020

Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin*.

1 reference

12 December 2020

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

1 reference

12 December 2020

Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation

1 reference

12 December 2020

The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States

1 reference

12 December 2020

Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States

1 reference

12 December 2020

Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation

1 reference

12 December 2020

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

12 December 2020

Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome

1 reference

12 December 2020

10.1007/S10620-006-9418-4

Identifiers

DOI

1 reference

12 November 2017

1 reference